IR (insulin receptor) is a tyrosine kinase receptor, known to stimulate the AKT pathway[30], and it has been suggested that the RB/E2F pathway, which is also known to play a role in cancer[31], has an effect on AKT activity via transcriptional regulation[32]. This evidence concerns the gene RB1 and cancer.